Biopharma

UAE’s Mubadala acquires full ownership of UCB Pharma’s China business with CBC Group

UAE’s Mubadala acquires full ownership of UCB Pharma’s China business with CBC Group

  • Value of transaction is expected to close in fourth quarter of 2024
  • Deal includes UCB’s neurology and allergy portfolios
By MIGUEL HADCHITY  ·